Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Palatin Technologies, Inc. Common Stock
(NY:
PTN
)
0.0941
UNCHANGED
Last Price
Updated: 8:00 PM EDT, May 7, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Palatin Technologies, Inc. Common Stock
< Previous
1
2
3
4
5
Next >
Top movers in Wednesday's session
May 07, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
May 07, 2025
Via
Benzinga
Wednesday's session: top gainers and losers
May 07, 2025
Curious to know what's happening on the US markets in the middle of the day on Wednesday? Join us as we explore the top gainers and losers in today's session.
Via
Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session.
May 07, 2025
In today's session, there are notable price gaps in the US markets on Wednesday. Take a closer look at the stocks that are gap up and gap down.
Via
Chartmill
These stocks that are showing activity before the opening bell on Wednesday.
May 07, 2025
Discover the top movers in Wednesday's pre-market session and stay informed about market dynamics.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
May 07, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
April 30, 2025
Via
Benzinga
Unusual volume stocks in Tuesday's session
April 22, 2025
On Tuesday, there are stocks with unusual volume. Let's take a look.
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 22, 2025
Via
Benzinga
What's going on in today's after hours session
April 21, 2025
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Via
Chartmill
Wondering what's happening in today's after-hours session?
April 17, 2025
After the closing bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.
Via
Chartmill
Unusual volume stocks are being observed in Tuesday's session.
April 15, 2025
Let's have a look at the stocks with an unusual volume in today's session.
Via
Chartmill
Stay updated with the stocks that are on the move in today's after-hours session.
April 14, 2025
As the regular session of the US market on Monday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Via
Chartmill
These stocks are moving in today's pre-market session
April 14, 2025
The US market is yet to commence its session on Monday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Via
Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 14, 2025
Via
Benzinga
Top 3 Biotech Stocks That Got Retail Street Buzzing Last Week: SMMT, PTN, RXRX
April 13, 2025
Positive expectations from key clinical trials, delisting fears and some regulatory changes triggered a flurry of discussions on Stocktwits for these tickers for the week ended April 11, 2025.
Via
Stocktwits
Topics
Animal Testing
Exposures
Animal Testing
Product Safety
Friday's after hours session: top gainers and losers
April 11, 2025
As the regular session of the US market concludes on Friday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.
Via
Chartmill
Top stock movements in today's session.
April 11, 2025
Wondering how the US markets performed in the middle of the day on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via
Chartmill
12 Health Care Stocks Moving In Friday's Intraday Session
April 11, 2025
Via
Benzinga
The market is filled with gapping stocks in Friday's session.
April 11, 2025
Today's session on Friday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
Via
Chartmill
Top movers in Friday's pre-market session
April 11, 2025
As we await the opening of the US market on Friday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Via
Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
April 11, 2025
Via
Benzinga
Why Argenx Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket
April 11, 2025
Via
Benzinga
Wondering what's happening in today's after-hours session?
April 10, 2025
The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Via
Chartmill
12 Health Care Stocks Moving In Thursday's After-Market Session
April 10, 2025
Via
Benzinga
Palatin Technologies Scores Triple Win with Breakthrough Results in Obesity, Colitis, and Kidney Disease
April 10, 2025
Palatin Technologies Scores Triple Win with Breakthrough Results in Obesity, Colitis, and Kidney Disease
Via
News Direct
Palatin Technologies’ UC Treatment Shows Remarkable 78% Clinical Response Rate in Phase 2 Topline Data – Potential Game-Changer for Millions Suffering from Ulcerative Colitis (NYSE: PTN)
March 31, 2025
Via
AB Newswire
Palatin Technologies' Obesity Drug Co-Administered With Eli Lilly's Blockbuster Drug Shows 4.4% Reduction In Weight
March 31, 2025
Palatin's study shows co-administering bremelanotide with tirzepatide led to greater weight loss than tirzepatide alone, with further analysis ongoing.
Via
Benzinga
Market Alert: Palatin's Disruptive Obesity Drug Combination Shows Groundbreaking Weight Loss Results in Phase 2 Topline Data (NYSE: PTN)
March 31, 2025
Market Alert: Palatin's Disruptive Obesity Drug Combination Shows Groundbreaking Weight Loss Results in Phase 2 Topline Data (NYSE: PTN)
Via
News Direct
Exposures
Product Safety
Palatin Technologies Touts Positive Results From Mid-Stage Study For Experimental Drug For Ulcerative Colitis, Halts Patients Enrollment Citing Strategic Focus
March 28, 2025
Palatin's PL8177 showed promising ulcerative colitis trial results, with strong clinical response rates. FDA granted orphan status to its obesity drug PL7737.
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.